Education
About Us
Working with TipRanks
Follow Us
Cara Therapeutics (CARA)
NASDAQ:CARA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.14M | $ 20.97M | $ 41.87M | $ 23.03M | $ 135.08M |
| Gross Profit | $ 7.14M | $ 14.79M | $ 34.60M | $ 21.47M | $ 28.01M |
| Operating Income | $ -58.38M | $ -121.50M | $ -87.53M | $ -89.08M | $ 5.38M |
| EBITDA | $ -62.60M | $ -117.65M | $ -83.80M | $ -88.19M | $ 5.59M |
| Net Income | $ -70.87M | $ -118.51M | $ -83.41M | $ -88.19M | $ 8.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 37.90M | $ 100.76M | $ 145.40M | $ 167.03M | $ 180.93M |
| Total Assets | $ 43.83M | $ 125.84M | $ 182.24M | $ 247.06M | $ 271.16M |
| Total Debt | $ 0.00 | $ 43.17M | $ 1.92M | $ 3.67M | $ 5.28M |
| Net Debt | $ -37.90M | $ -8.61M | $ -61.82M | $ -9.78M | $ -26.41M |
| Total Liabilities | $ 48.42M | $ 68.76M | $ 23.46M | $ 19.53M | $ 22.16M |
| Stockholders' Equity | $ -4.59M | $ 57.09M | $ 158.78M | $ 227.52M | $ 249.00M |
| Cash Flow | |||||
| Free Cash Flow | $ -61.96M | $ -94.45M | $ -78.77M | $ -60.13M | $ -5.84M |
| Operating Cash Flow | $ -60.92M | $ -92.08M | $ -78.73M | $ -60.09M | $ -5.49M |
| Investing Cash Flow | $ 48.74M | $ 43.46M | $ 128.71M | $ -4.75M | $ -20.27M |
| Financing Cash Flow | $ -3.60M | $ 38.15M | $ 311.00K | $ 46.61M | $ 39.14M |